Fuad El-Hibri
Executive Chairman Fuad El-Hibri
Executive Chairman
Mr. El-Hibri is the founder and executive chairman of the board of Emergent BioSolutions Inc. He served as Emergent’s chief executive officer since its inception in September 1998 until March 2012. His career in life sciences began in the early 90s with Porton Products, Ltd., a private biotechnology company in the U.K. Mr. El-Hibri organized and co-directed a management buyout of Porton and formed Speywood Holdings, Ltd., a recapitalized biopharmaceutical company with marketed biologics pr... |
|
 |
Daniel J. Abdun-Nabi
Director Daniel J. Abdun-Nabi
Director
Mr. Abdun-Nabi has served as a board member since May 2009, chief executive officer since April 2012, and president since March 2007. He formerly served as chief operating officer from May 2007 to March 2012. Mr. Abdun-Nabi served as senior vice president corporate affairs and general counsel from December 2004 to April 2007, secretary from December 2004 to January 2008, and vice president and general counsel from May 2004 to December 2004. Prior to joining the company, Mr. Abdun-Nabi se... |
|
|
Dr. Sue Bailey
Director Dr. Sue Bailey
Director
Dr. Sue Bailey has served as a director since June 2007. She is currently advisor to the director of the National Cancer Institute. Prior to that, Dr. Bailey served as a news analyst for NBC Universal, a media and entertainment company, from 2001 to 2006. She served as Administrator, National Highway Traffic Safety Administration from 2000 to 2001, as Assistant Secretary of Defense (Health Affairs) from 1998 to 2000, and as Deputy Assistant Secretary of Defense (Clinical Services) from 1994 to 1... |
|
|
Zsolt Harsanyi, Ph.D.
Director Zsolt Harsanyi, Ph.D.
Director
Dr. Harsanyi has served as a director since August 2004. Dr. Harsanyi has served as chairman of the board of N-Gene Research Laboratories, Inc. since March 2011. Previously, he served as chief executive officer and chairman of the board of directors of Exponential Biotherapies Inc., a private biotechnology company, from December 2004 through February 2011. Dr. Harsanyi served as president of Porton International plc, a pharmaceutical and vaccine company, from January 1983 to December 20... |
|
|
John E. Niederhuber, M.D.
Director John E. Niederhuber, M.D.
Director
Dr. Niederhuber has served as a director since August 2010. He presently serves as executive vice president of Inova Health System and chief executive officer of Inova Translational Medicine Institute. He previously served as the director of the National Cancer Institute (NCI) from 2005 to 2010. As NCI director, Dr. Niederhuber's accomplishments include advancing drug and technology innovation and technology infrastructure, bringing cancer science to patients through community cancer centers, an... |
|
|
Ronald B. Richard
Lead Independent Director Ronald B. Richard
Lead Independent Director
Mr. Richard has served as a director since January 2005. Mr. Richard has served as the president and chief executive officer of the Cleveland Foundation, the nation’s oldest community foundation, since June 2003. From August 2002 to February 2003, Mr. Richard served as president of Stem Cell Preservation, Inc., a start-up medical research company. After leaving Stem Cell Preservation and prior to joining Emergent, Mr. Richard served as a strategic business advisor for IGEN International, Inc., a... |
|
|
Louis W. Sullivan, M.D.
Director Louis W. Sullivan, M.D.
Director
Dr. Sullivan has served as a director since June 2006. Dr. Sullivan has served as president emeritus of Morehouse School of Medicine since July 2002. Dr. Sullivan served as president of Morehouse School of Medicine from 1981 to 1989 and from 1993 to 2002. From 1989 to 1993, Dr. Sullivan was Secretary of HHS. Dr. Sullivan also serves on the boards of directors of United Therapeutics Corporation, BioSante Pharmaceuticals, Inhibitex, Inc. and Henry Schein, Inc., publicly traded biotechnology compan... |
|
|
Marvin L. White
Director Marvin L. White
Director
Mr. Marvin L. White has served as a director since June 2010. At St. Vincent Health, Mr. White is system vice president & chief financial officer, and is responsible for finance, materials management, accounting, patient financial services, and managed care for all 19 hospitals and 36 joint ventures.
Prior to joining St. Vincent Health in 2008, Mr. White was executive director and chief financial officer of LillyUSA, a subsidiary of Eli Lilly and Company, where he also held lea... |
|
|
